Market Pulse
March 23, 2020

Coronavirus Update: The Outlook for Global Credit


Market Pulse

Coronavirus Update: The Outlook for Global Credit

Coronavirus Update: The Outlook for Global Credit

Share Icon

March 23, 2020



I will always value the advice I was given at the start of my career─limit defaults and take advantage of price volatility─and look to the valuation of the largest U.S. banks, buy when the spread exceeds +150 and sell below +100 (mean reversion is a feature of fixed income markets with monetary/fiscal policy support a necessary condition).

To put the latest moves in context, the large banks were below +100 in January, 10 days ago we saw spreads in the +210 to +180 range, this week we saw issuance in excess of +300. These are significantly important institutions, they are regulated, they have lots of capital but also take credit risk to the broad economy. We are confident the spread in 12 months will be lower, but short term we are a prisoner of fortune to the next headline and market flow.


Markets are offering value but given the uncertainty in the outlook one can’t be confident better opportunities will not occur. We increased our credit exposure by a small amount in the second half of the week taking advantage of the new issue supply discount in high quality issuers, but continue to keep powder dry recognising more issuers will likely take a prudent approach and issue debt at attractive levels.

For the market to consolidate we are looking at 3 key indicators to give confidence to investors

  • A vaccine for the coronavirus
  • A slowdown in new cases (including consideration of re-infection)
  • The market stabilising and finding a clearing level for risk

Market Levels (credit spreads)

  3/20/2020 3/13/2020 2/28/2020 1/31/2020 12/30/2019 12/31/2008
U.S. IG +363 +216 +122 +102 +94 +555
EURO IG +236 +182 +114 +94 +93 +461
GBP IG +273 +199 +139 +122 +127 +565
U.S. HY +1013 +727 +500 +390 +330 +1662
EURO HY +876 +657 +410 +329 +285 +1953


Macro Backdrop

The economy (and asset prices) have been hit by the containment measures necessary to halt the spread of the coronavirus and the related fall in oil prices following the breakdown of OPEC discussions. Markets are looking for clarity over (1) the length of time isolation policies will remain in force and (2) the time to identify a vaccine. Hopes of a “V” shaped rebound are no longer the base case as questions over the assumption that warm weather will reduce the impact of the virus and health experts warning that a vaccine is months and not weeks away are repricing markets. The reality is a base case no longer exists with the limited credible data.

Governments have responded to the crisis by prioritising health as the primary goal. The need to reduce overcrowding and limited medical facilities have required a policy of isolation across most developed countries at the cost of economic activity. In response to the economic impact central banks have eased  monetary policy with rate cuts and additional QE asset purchase programs. Across most developed markets, rates have been moved to the zero bound. Fiscal policy has been more limited but is expected to increase over the coming weeks. While monetary policy can provide liquidity and low rates, the economic cost is being borne by shareholders and workers to date. The next stage of support will be direct public payments to the private sector (like the UK announcement to pay 80% of wages for workers at risk of redundancy caused by the coronavirus shutdowns) whereby the cost is socialised.

Corporate Impact

Many companies across a range of sectors are being hit by a loss of revenue. Earnings will fall and management teams are withdrawing guidance given the lack of visibility over the outlook. Financial metrics will weaken as leverage increases and refinancing will be less certain as debt costs increase. On a positive note, low interest rates, recent extensions of maturities and Government liquidity facilities will all help. Looking at sectors specifically, questions are being asked on a broad range of topics including (1) how deeply will consumer demand and credit payments be impacted if unemployment increases  (2) how big are the banks non-performing loan portfolios if companies have no earnings (3) what is the value of asset portfolios (4) how sensitive is the business to an oil price below 30 dollars a barrel (5) what supply chain disruptions exist. . .in short, no industry seems immune to risks.

Rating agencies are challenged. Do they look through the crisis or do they respond to the (hopefully short term) weaker economic and financial data. We have started to see early downgrades in several sectors including Energy, Airlines, Gaming and other Leisure sectors, but as yet there is no clear pattern of response across the broad market.

In conclusion, management is justified in withdrawing guidance, investors are correct to demand a higher risk premium for uncertainty.


Over the past week we have seen significant selling of corporate credit as evidenced by the fund flow data. The reason for selling is a combination of risk reduction, need for liquidity and profit taking, high quality fixed income has outperformed many other assets. Demand has been limited, although supply from high quality issuers towards the end of the week in both USD and Euro at discounted spreads suggests at a price there is demand.


Spreads spent the first half of the week widening on a lack of demand and finished the week widening as supply repriced the market. Key to the coming weeks will be whether the corporate market has demonstrated market efficiency, have we found the clearing price for risk (see table above).

Looking to history, IG credit spreads would seem to be pricing a recession but not a severe recession accompanied by high defaults (a scenario not seen in modern times).

This communication is only intended for Professional Clients and not to be forwarded for onward distribution.
Managing Director
Global Fixed Income Team

The views and opinions are those of the author as of the date of publication and are subject to change at any time due to market or economic conditions and may not necessarily come to pass. Furthermore, the views will not be updated or otherwise revised to reflect information that subsequently becomes available or circumstances existing, or changes occurring, after the date of publication. The views expressed do not reflect the opinions of all portfolio managers at Morgan Stanley Investment Management (MSIM) or the views of the firm as a whole, and may not be reflected in all the strategies and products that the Firm offers.

Forecasts and/or estimates provided herein are subject to change and may not actually come to pass. Information regarding expected market returns and market outlooks is based on the research, analysis and opinions of the authors. These conclusions are speculative in nature, may not come to pass and are not intended to predict the future performance of any specific MSIM product.

Certain information herein is based on data obtained from third party sources believed to be reliable. However, we have not verified this information, and we make no representations whatsoever as to its accuracy or completeness.

The information herein is a general communications which is not impartial and has been prepared solely for information and educational purposes and does not constitute an offer or a recommendation to buy or sell any particular security or to adopt any specific investment strategy. The material contained herein has not been based on a consideration of any individual client circumstances and is not investment advice, nor should it be construed in any way as tax, accounting, legal or regulatory advice. To that end, investors should seek independent legal and financial advice, including advice as to tax consequences, before making any investment decision.

Past performance is no guarantee of future results.

This communication is not a product of Morgan Stanley’s Research Department and should not be regarded as a research recommendation. The information contained herein has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

There is no guarantee that any investment strategy will work under all market conditions, and each investor should evaluate their ability to invest for the long-term, especially during periods of downturn in the market. Prior to investing, investors should carefully review the strategy’s / product’s relevant offering document. There are important differences in how the strategy is carried out in each of the investment vehicles.

This communication is only intended for and will only be distributed to persons resident in jurisdictions where such distribution or availability would not be contrary to local laws or regulations.

Ireland: Morgan Stanley Investment Management (Ireland) Limited. Registered Office: The Observatory, 7-11 Sir John Rogerson's Quay, Dublin 2, Ireland. Registered in Ireland under company number 616662.  Regulated by the Central Bank of Ireland. United Kingdom: Morgan Stanley Investment Management Limited is authorised and regulated by the Financial Conduct Authority. Registered in England. Registered No. 1981121. Registered Office: 25 Cabot Square, Canary Wharf, London E14 4QA, authorised and regulated by the Financial Conduct Authority. Dubai: Morgan Stanley Investment Management Limited (Representative Office, Unit Precinct 3-7th Floor-Unit 701 and 702, Level 7, Gate Precinct Building 3, Dubai International Financial Centre, Dubai, 506501, United Arab Emirates. Telephone: +97 (0)14 709 7158). Germany: Morgan Stanley Investment Management Limited Niederlassung Deutschland, Grosse Gallusstrasse 18, 60312 Frankfurt am Main, Germany (Gattung: Zweigniederlassung (FDI) gem. § 53b KWG). Italy: Morgan Stanley Investment Management Limited, Milan Branch (Sede Secondaria di Milano) is a branch of Morgan Stanley Investment Management Limited, a company registered in the UK, authorised and regulated by the Financial Conduct Authority (FCA), and whose registered office is at 25 Cabot Square, Canary Wharf, London, E14 4QA. Morgan Stanley Investment Management Limited Milan Branch (Sede Secondaria di Milano) with seat in Palazzo Serbelloni Corso Venezia, 16 20121 Milano, Italy, is registered in Italy with company number and VAT number 08829360968. The Netherlands: Morgan Stanley Investment Management, Rembrandt Tower, 11th Floor Amstelplein 1 1096HA, Netherlands. Telephone: 31 2-0462-1300. Morgan Stanley Investment Management is a branch office of Morgan Stanley Investment Management Limited. Morgan Stanley Investment Management Limited is authorised and regulated by the Financial Conduct Authority in the United Kingdom. Switzerland: Morgan Stanley & Co. International plc, London, Zurich Branch Authorised and regulated by the Eidgenössische Finanzmarktaufsicht (“FINMA”). Registered with the Register of Commerce Zurich CHE-115.415.770. Registered Office: Beethovenstrasse 33, 8002 Zurich, Switzerland, Telephone +41 (0) 44 588 1000. Facsimile Fax: +41(0) 44 588 1074.

U.S.: A separately managed account may not be suitable for all investors. Separate accounts managed according to the Strategy include a number of securities and will not necessarily track the performance of any index. Please consider the investment objectives, risks and fees of the Strategy carefully before investing. A minimum asset level is required. For important information about the investment manager, please refer to Form ADV Part 2.

Please consider the investment objectives, risks, charges and expenses of the funds carefully before investing. The prospectuses contain this and other information about the funds. To obtain   a prospectus please download one at or call 1-800-548-7786. Please read the prospectus carefully before investing.

Morgan Stanley Distribution, Inc. serves as the distributor for Morgan Stanley Funds.


Hong Kong: This document has been issued by Morgan Stanley Asia Limited for use in Hong Kong and shall only be made available to “professional investors” as defined under the Securities and Futures Ordinance of Hong Kong (Cap 571). The contents of this document have not been reviewed Futures Commission in Hong Kong. Accordingly, save where an exemption is available under the relevant law, this document shall not be issued, circulated, distributed, directed at, or made available to, the public in Hong Kong. Singapore: This publication should not be considered to be the subject of an invitation for subscription or purchase, whether directly or indirectly, to the public or any member of the public in Singapore other than (i) to an institutional investor under section 304 of the Securities and Futures Act, Chapter 289 of Singapore ("SFA"), (ii) to a "relevant person" (which includes an accredited investor) pursuant to section 305 of the SFA, and such distribution is in accordance with the conditions specified in section 305 of the SFA; or (iii) otherwise pursuant to, and in accordance with the conditions of, any other applicable provision of the SFA. In particular, for investment funds that are not authorized or recognized by the MAS, units in such funds are not allowed to be offered to the retail public; any written material issued to persons as aforementioned in connection with an offer is not a prospectus as defined in the SFA and, accordingly, statutory liability under the SFA in relation to the content of prospectuses does not apply, and investors should consider carefully whether the investment is suitable for them. This publication has not been reviewed by the Monetary Authority of Singapore. Australia: This publication is disseminated in Australia by Morgan Stanley Investment Management (Australia) Pty Limited ACN: 122040037, AFSL No. 314182, which accept responsibility for its contents. This publication, and any access to it, is intended only for “wholesale clients” within the meaning of the Australian Corporations Act.

Japan: For professional investors, this document is circulated or distributed for informational purposes only. For those who are not professional investors, this document is provided in relation to Morgan Stanley Investment Management (Japan) Co., Ltd. (“MSIMJ”)’s business with respect to discretionary investment management agreements (“IMA”) and investment advisory agreements (“IAA”). This is not for the purpose of a recommendation or solicitation of transactions or offers any particular financial instruments. Under an IMA, with respect to management of assets of a client, the client prescribes basic management policies in advance and commissions MSIMJ to make all investment decisions based on an analysis of the value, etc. of the securities, and MSIMJ accepts such commission. The client shall delegate to MSIMJ the authorities necessary for making investment. MSIMJ exercises the delegated authorities based on investment decisions of MSIMJ, and the client shall not make individual instructions. All investment profits and losses belong to the clients; principal is not guaranteed. Please consider the investment objectives and nature of risks before investing. As an investment advisory fee for an IAA or an IMA, the amount of assets subject to the contract multiplied by a certain rate (the upper limit is 2.20% per annum (including tax)) shall be incurred in proportion to the contract period. For some strategies, a contingency fee may be incurred in addition to the fee mentioned above. Indirect charges also may be incurred, such as brokerage commissions for incorporated securities. Since these charges and expenses are different depending on a contract and other factors, MSIMJ cannot present the rates, upper limits, etc. in advance. All clients should read the Documents Provided Prior to the Conclusion of a Contract carefully before executing an agreement. This document is disseminated in Japan by MSIMJ, Registered No. 410 (Director of Kanto Local Finance Bureau (Financial Instruments Firms)), Membership: the Japan Securities Dealers Association, The Investment Trusts Association, Japan, the Japan Investment Advisers Association and the Type II Financial Instruments Firms Association.

EMEA: This marketing communication has been issued by Morgan Stanley Investment Management Limited (“MSIM”). Authorised and regulated by the Financial Conduct Authority. Registered in England No. 1981121. Registered Office: 25 Cabot Square, Canary Wharf, London E14 4QA.

Charts and graphs provided herein are for illustrative purposes only.

The information contained in this communication is not a research recommendation or ‘investment research’ and is classified as a ‘Marketing Communication’ in accordance with the applicable European or Swiss regulation. This means that this marketing communication (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research (b) is not subject to any prohibition on dealing ahead of the dissemination of investment research.

MSIM has not authorised financial intermediaries to use and to distribute this document, unless such use and distribution is made in accordance with applicable law and regulation. Additionally, financial intermediaries are required to satisfy themselves that the information in this document is suitable for any person to whom they provide this document in view of that person’s circumstances and purpose. MSIM shall not be liable for, and accepts no liability for, the use or misuse of this document by any such financial intermediary.

The whole or any part of this work may not be reproduced, copied or transmitted or any of its contents disclosed to third parties without MSIM Ireland’s express written consent.

All information contained herein is proprietary and is protected under copyright law.

Morgan Stanley Investment Management is the asset management division of Morgan Stanley.


It is important that users read the Terms of Use before proceeding as it explains certain legal and regulatory restrictions applicable to the dissemination of information pertaining to Morgan Stanley Investment Management's investment products.

The services described on this website may not be available in all jurisdictions or to all persons. For further details, please see our Terms of Use.

Privacy & Cookies    •    Terms of Use

©  Morgan Stanley. All rights reserved.